178 related articles for article (PubMed ID: 27998070)
61. Controlled drug release system based on cyclodextrin-conjugated poly(lactic acid)-b-poly(ethylene glycol) micelles.
He Q; Wu W; Xiu K; Zhang Q; Xu F; Li J
Int J Pharm; 2013 Feb; 443(1-2):110-9. PubMed ID: 23328682
[TBL] [Abstract][Full Text] [Related]
62. Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies.
Martins S; Tho I; Reimold I; Fricker G; Souto E; Ferreira D; Brandl M
Int J Pharm; 2012 Dec; 439(1-2):49-62. PubMed ID: 23046667
[TBL] [Abstract][Full Text] [Related]
63. Rapidly cell-penetrating and reductive milieu-responsive nanoaggregates assembled from an amphiphilic folate-camptothecin prodrug for enhanced drug delivery and controlled release.
Xu Z; Hou M; Shi X; Gao YE; Xue P; Liu S; Kang Y
Biomater Sci; 2017 Feb; 5(3):444-454. PubMed ID: 28058423
[TBL] [Abstract][Full Text] [Related]
64. Oral delivery of camptothecin using cyclodextrin/poly(anhydride) nanoparticles.
Huarte J; Espuelas S; Lai Y; He B; Tang J; Irache JM
Int J Pharm; 2016 Jun; 506(1-2):116-28. PubMed ID: 27102993
[TBL] [Abstract][Full Text] [Related]
65. Chitosan-based nanocarriers with pH and light dual response for anticancer drug delivery.
Meng L; Huang W; Wang D; Huang X; Zhu X; Yan D
Biomacromolecules; 2013 Aug; 14(8):2601-10. PubMed ID: 23819825
[TBL] [Abstract][Full Text] [Related]
66. Molecular encapsulator on the surface of magnetic nanoparticles. Controlled drug release from calcium Ferrite/Cyclodextrin-tethered polymer hybrid.
Ramasamy S; Samathanam B; Reuther H; Adyanpuram MNMS; Enoch IVMV; Potzger K
Colloids Surf B Biointerfaces; 2018 Jan; 161():347-355. PubMed ID: 29100128
[TBL] [Abstract][Full Text] [Related]
67. Biologically active camptothecin derivatives for incorporation into liposome bilayers and lipid emulsions.
Lundberg BB
Anticancer Drug Des; 1998 Jul; 13(5):453-61. PubMed ID: 9702210
[TBL] [Abstract][Full Text] [Related]
68. A supramolecular vesicle of camptothecin for its water dispersion and controllable releasing.
Ma M; Shang W; Xing P; Li S; Chu X; Hao A; Liu G; Zhang Y
Carbohydr Res; 2015 Jan; 402():208-14. PubMed ID: 25498021
[TBL] [Abstract][Full Text] [Related]
69. Antitumor activity of beta-cyclodextrin polymer-camptothecin conjugates.
Cheng J; Khin KT; Davis ME
Mol Pharm; 2004; 1(3):183-93. PubMed ID: 15981921
[TBL] [Abstract][Full Text] [Related]
70. Preparation, characterization, and controlled release of novel nanoparticles based on MMA/beta-CD copolymers.
Liu YY; Yu Y; Zhang GB; Tang MF
Macromol Biosci; 2007 Dec; 7(12):1250-7. PubMed ID: 17724789
[TBL] [Abstract][Full Text] [Related]
71. Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability.
Watanabe M; Kawano K; Yokoyama M; Opanasopit P; Okano T; Maitani Y
Int J Pharm; 2006 Feb; 308(1-2):183-9. PubMed ID: 16324807
[TBL] [Abstract][Full Text] [Related]
72. Ultrasound-responsive nanobubbles contained with peptide-camptothecin conjugates for targeted drug delivery.
Xie X; Lin W; Liu H; Deng J; Chen Y; Liu H; Fu X; Yang Y
Drug Deliv; 2016 Oct; 23(8):2756-2764. PubMed ID: 26289216
[TBL] [Abstract][Full Text] [Related]
73. Polysaccharide-gold nanocluster supramolecular conjugates as a versatile platform for the targeted delivery of anticancer drugs.
Li N; Chen Y; Zhang YM; Yang Y; Su Y; Chen JT; Liu Y
Sci Rep; 2014 Feb; 4():4164. PubMed ID: 24566666
[TBL] [Abstract][Full Text] [Related]
74. Effect of hydroxypropyl-beta-cyclodextrin-complexation and pH on solubility of camptothecin.
Saetern AM; Nguyen NB; Bauer-Brandl A; Brandl M
Int J Pharm; 2004 Oct; 284(1-2):61-8. PubMed ID: 15454297
[TBL] [Abstract][Full Text] [Related]
75. Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery.
Bilensoy E; Gürkaynak O; Doğan AL; Hincal AA
Int J Pharm; 2008 Jan; 347(1-2):163-70. PubMed ID: 17689901
[TBL] [Abstract][Full Text] [Related]
76. A new targeted delivery approach by functionalizing drug nanocrystals through polydopamine coating.
Zhan H; Jagtiani T; Liang JF
Eur J Pharm Biopharm; 2017 May; 114():221-229. PubMed ID: 28161549
[TBL] [Abstract][Full Text] [Related]
77. Hydrophilic mesoporous carbon nanoparticles as carriers for sustained release of hydrophobic anti-cancer drugs.
Gu J; Su S; Li Y; He Q; Shi J
Chem Commun (Camb); 2011 Feb; 47(7):2101-3. PubMed ID: 21183990
[TBL] [Abstract][Full Text] [Related]
78. Paclitaxel-Loaded β-Cyclodextrin-Modified Poly(Acrylic Acid) Nanoparticles through Multivalent Inclusion for Anticancer Therapy.
Yuan S; Chen J; Sheng J; Hu Y; Jiang Z
Macromol Biosci; 2016 Mar; 16(3):341-9. PubMed ID: 26611878
[TBL] [Abstract][Full Text] [Related]
79. Probing a dipeptide-based supramolecular assembly as an efficient camptothecin delivering carrier for cancer therapy: computational simulations and experimental validations.
Sun M; Zhang X; Gao Z; Liu T; Luo C; Zhao Y; Liu Y; He Z; Wang J; Sun J
Nanoscale; 2019 Feb; 11(9):3864-3876. PubMed ID: 30758022
[TBL] [Abstract][Full Text] [Related]
80. Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin.
Mu L; Elbayoumi TA; Torchilin VP
Int J Pharm; 2005 Dec; 306(1-2):142-9. PubMed ID: 16242875
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
